129 related articles for article (PubMed ID: 18664346)
1. [Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].
Lou SY; Liu Y; Ma YY; Chen HY; Chen WH; Ying J; He YM; Wang WJ
Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):793-8. PubMed ID: 18664346
[TBL] [Abstract][Full Text] [Related]
2. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
4. [Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis].
Liu XD; Wang M; Li YZ
Zhongguo Zhen Jiu; 2010 Aug; 30(8):637-41. PubMed ID: 20942279
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and waist circumference in non-alcoholic fatty liver disease.
Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
9. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
10. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
[TBL] [Abstract][Full Text] [Related]
11. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
Askari F; Rashidkhani B; Hekmatdoost A
Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
Zhang H; Feng Q; Li HS; Chen SD; Wang XN; Peng JH; Zhang N; Hu YY
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):928-33. PubMed ID: 18782536
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
14. Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.
Li Y; Li-Li Z; Qin L; Ying W
Hepatogastroenterology; 2010; 57(97):103-6. PubMed ID: 20422882
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
16. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
Chou SC; Chen KW; Hwang JS; Lu WT; Chu YY; Lin JD; Chang HJ; See LC
Altern Ther Health Med; 2006; 12(3):34-9. PubMed ID: 16708768
[TBL] [Abstract][Full Text] [Related]
17. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
18. [Observation on therapeutic effect of acupuncture for treatment of patients with nonalcoholic steatohepatitis].
Meng SX
Zhongguo Zhen Jiu; 2009 Aug; 29(8):616-8. PubMed ID: 19947262
[TBL] [Abstract][Full Text] [Related]
19. [Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease].
Xie X; Meng X; Zhou X; Shu X; Kong H
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3032-5. PubMed ID: 22308697
[TBL] [Abstract][Full Text] [Related]
20. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
Zhou WD; Yang YL; Che ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
